Skip to content

Evaluating the Efficacy of Suture Mesh vs. Planar Mesh in Ventral Hernia Treatment

Mesh Matters: Evaluating the Efficacy of Suture Mesh vs. Planar Mesh in Ventral Hernia Treatment - a Randomized, Blinded Multicenter Study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07476560
Acronym
MeMa
Enrollment
280
Registered
2026-03-17
Start date
2026-01-05
Completion date
2032-12-31
Last updated
2026-03-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abdominal Wall Hernia, Epigastric Hernia Repair, Umbilical Hernia Repair

Brief summary

The goal of this clinical trial is to investigate whether mesh-suture affects wound complication rates, patient-reported quality of life, and operation time in adult patients undergoing surgery for small ventral hernias. The main questions it aims to answer are: Does mesh-suture reduce wound complication rates compared to planar mesh? Does mesh-suture improve patient-reported quality of life(QoL) and affect operation time compared to planar mesh? Comparison group: Researchers will compare standard treatment with planar mesh to the interventional treatment with mesh-suture to see whether mesh-suture leads to fewer complications, better quality of life, and shorter operation time. Participants will: Be randomized to receive either planar mesh or mesh-suture during hernia repair surgery. Undergo standardized preoperative assessment, including baseline data and QoL scoring. Attend a postoperative visit on day 7-13 for wound inspection and ultrasound. Complete QoL assessments at 90 days (telephone follow-up). Have operation time recorded and medical records reviewed for readmissions within 90 days.

Interventions

DEVICEmesh suture

mesh suture

DEVICEplanar mesh

planar mesh

Sponsors

Regionshospital Nordjylland
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ventral hernia (maximum size 3 × 3 cm) measured with Ultrasound or CT. * Participants must be eligible for surgical repair using either mesh-suture or planar mesh

Exclusion criteria

* Age \< 18 years. * Acute (emergent) operation. * Pregnancy. * Women with plans for future pregnancies. * Withdrawal of informed consent during admission.

Design outcomes

Primary

MeasureTime frameDescription
Surgical Site Occurrences (SSO) Assessed by Clinical Examination and Ultrasound7-13 days after operationDefinition: We will apply the standardized CDC (Centers for Disease Control and Prevention ) and VHWG (Ventral Hernia Working Group) definitions for SSO. Evaluation: Clinical examination. Additionally, an ultrasound examination will be performed.

Secondary

MeasureTime frameDescription
Abdominal Hernia-Q Questionnairepreoperative, postoperative day 10, day 90Scale description: Disease-specific patient-reported outcome measure for abdominal hernia symptoms and quality of life. Score range: Each domain ranges from 1 to 4, where higher scores indicate better health status and fewer symptoms.
EQ-5D-5L Index Scorepreoperative, postoperative day 10, day 90Scale description: Generic health-related quality-of-life instrument assessing five dimensions of health. Score range: The Index Score ranges from \< 0 (worst health state, depending on country value set) to 1 (perfect health) and
EQ-VAS (Visual Analogue Scale)preoperative, postoperative day 10, day 90Patients rate their overall health on a vertical scale from 0 to 100. Interpretation: Higher scores indicate better overall health-related quality of life.
DURATION OF SURGERYThe time interval from the first incision to the last stitch is setOperation time measured in minutes

Countries

Denmark

Contacts

CONTACTVitaly A Gameza
vitgam@rn.dk045 97640520
CONTACTKatrine Holte
k.holte@rn.dk045 97640520
STUDY_CHAIRNils Brandenburger

Regionhospital Nordjylland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 2, 2026